Ritonavir enables combined therapy with rifampin and saquinavir.
Veldkamp
A I
AI
Slotervaart Hospital, Department of Pharmacy and Pharmacology, 1066 EC Amsterdam, The Netherlands. APABG@SLZ.NL
Hoetelmans
R M
RM
Beijnen
J H
JH
Mulder
J W
JW
Meenhorst
P L
PL
D004357:Drug Synergism; D004359:Drug Therapy, Combination; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000493:pharmacokinetics / Q000627:therapeutic use; D015497:HIV-1 / Q000187:drug effects; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D012293:Rifampin / Q000627:therapeutic use; D019438:Ritonavir / Q000627:therapeutic use; D019258:Saquinavir / Q000493:pharmacokinetics / Q000627:therapeutic use; D014376:Tuberculosis / Q000150:complications / Q000188:drug therapy
D004791:Enzyme Inhibitors; D017320:HIV Protease Inhibitors; D019258:Saquinavir; D019438:Ritonavir; D012293:Rifampin